Literature DB >> 21688104

Primary ileus after total hip arthroplasty: rare complication or sentinel event?

Alberto Vannelli1, Domenico Laveneziana, Mario Rampa, Luigi Battaglia, Ermanno Leo.   

Abstract

The incidence of hip dislocation after primary total hip arthroplasty (THA) has been reported to range from 1 to 25% in THA revision. Here, we explore the hypothesis that there is a correlation between postoperative ileus (POI) and THA dislocation, with POI after THA possibly representing a sentinel event. We retrospectively identified a cohort of 529 consecutive patients who underwent hip arthroplasty from 2008 to 2010. Of them, 251 were male and 278 were female, and a mean average for age of 71.5 (range 65-76). In particular, 19 THA patients showed signs of gastrointestinal complications, and therapeutic consultation was performed with the onset of the first intestinal symptom. Of these 19 patients, 3 THA patients developed POI within 1 week after surgical treatment. A conservative treatment was practised and it seemed to improve the condition: canalization returned and all patients were discharged from the hospital. Unfortunately, two of these patients were readmitted after 2 weeks due to THA dislocation and they underwent THA revision and were discharged from the hospital 7 days later. Follow-up revealed no further problems at 6 months. Our clinical experience with these post-THA primary ileus patients raises the possibility that intra-abdominal symptoms represent a sentinel event in THA dislocation. THA dislocation using neuronal pathway of immunomodulation may modulate POI. Since the risk of THA dislocation is the greatest in the first 3 months after hip arthroplasty, the surgeon should be familiar with the relationship between THA and various pelvic and visceral complications to ensure that POI remains only a rare complication.

Entities:  

Mesh:

Year:  2011        PMID: 21688104     DOI: 10.1007/s13304-011-0084-5

Source DB:  PubMed          Journal:  Updates Surg        ISSN: 2038-131X


  33 in total

1.  Acute colonic pseudo-obstruction after elective total joint arthroplasty.

Authors:  B A Petrisor; D T Petruccelli; M J Winemaker; J V de Beer
Journal:  J Arthroplasty       Date:  2001-12       Impact factor: 4.757

2.  Severe pelvic pain and extrinsic compression of the rectum: late complication of total hip arthroplasty.

Authors:  Y Tomak; B Gulman; Z Malazgirt; T N Karaismailoglu
Journal:  J Orthop Sci       Date:  2001       Impact factor: 1.601

3.  Ogilvie's syndrome after lower extremity arthroplasty.

Authors:  A W elMaraghy; E H Schemitsch; M J Burnstein; J P Waddell
Journal:  Can J Surg       Date:  1999-04       Impact factor: 2.089

Review 4.  Does surgical approach affect total hip arthroplasty dislocation rates?

Authors:  Michael S Kwon; Michael Kuskowski; Kevin J Mulhall; William Macaulay; Thomas E Brown; Khaled J Saleh
Journal:  Clin Orthop Relat Res       Date:  2006-06       Impact factor: 4.176

5.  Small bowel volvulus following total hip replacement.

Authors:  P M King; H M Crawshaw; A H Ross
Journal:  Br J Surg       Date:  1983-02       Impact factor: 6.939

6.  Acute pseudo-obstruction of the colon as a postoperative complication of hip arthroplasty.

Authors:  H D Clarke; D J Berry; D R Larson
Journal:  J Bone Joint Surg Am       Date:  1997-11       Impact factor: 5.284

Review 7.  Postoperative ileus: a review.

Authors:  Mirza K Baig; Steven D Wexner
Journal:  Dis Colon Rectum       Date:  2004-02-25       Impact factor: 4.585

8.  C-reactive protein levels after 4 types of arthroplasty.

Authors:  Hao Shen; Nanxin Zhang; Xianlong Zhang; Weiping Ji
Journal:  Acta Orthop       Date:  2009-06       Impact factor: 3.717

9.  Pelvic lymphedema: truth or fiction?

Authors:  Alberto Vannelli; Luigi Battaglia; Elia Poiasina; Ermanno Leo
Journal:  Med Hypotheses       Date:  2008-12-10       Impact factor: 1.538

10.  Late dislocation after total hip arthroplasty.

Authors:  R M D Meek; D B Allan; G McPhillips; L Kerr; C R Howie
Journal:  Clin Med Res       Date:  2008-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.